ServisFirst Bancshares, Inc. (SFBS) At $43.08 Forms Top; Platinum Investment Management LTD Decreased Foundation Medicine (FMI) Stake By $2.57 Million

Foundation Medicine, Inc. (NASDAQ:FMI) Logo

ServisFirst Bancshares, Inc. (SFBS) formed multiple top with $46.96 target or 9.00% above today’s $43.08 share price. ServisFirst Bancshares, Inc. (SFBS) has $2.29 billion valuation. The stock increased 0.51% or $0.22 during the last trading session, reaching $43.08. About 78,176 shares traded. ServisFirst Bancshares, Inc. (NASDAQ:SFBS) has risen 15.16% since May 17, 2017 and is uptrending. It has outperformed by 3.61% the S&P500.

Platinum Investment Management Ltd decreased Foundation Medicine Inc (FMI) stake by 41.68% reported in 2017Q4 SEC filing. Platinum Investment Management Ltd sold 37,800 shares as Foundation Medicine Inc (FMI)’s stock rose 20.73%. The Platinum Investment Management Ltd holds 52,900 shares with $3.61M value, down from 90,700 last quarter. Foundation Medicine Inc now has $2.97 billion valuation. The stock increased 3.81% or $2.95 during the last trading session, reaching $80.3. About 373,710 shares traded or 14.86% up from the average. Foundation Medicine, Inc. (NASDAQ:FMI) has risen 134.36% since May 17, 2017 and is uptrending. It has outperformed by 122.81% the S&P500.

Analysts await Foundation Medicine, Inc. (NASDAQ:FMI) to report earnings on August, 7. They expect $-1.11 EPS, up 10.48% or $0.13 from last year’s $-1.24 per share. After $-1.02 actual EPS reported by Foundation Medicine, Inc. for the previous quarter, Wall Street now forecasts 8.82% negative EPS growth.

Among 11 analysts covering Foundation Medicine (NASDAQ:FMI), 2 have Buy rating, 0 Sell and 9 Hold. Therefore 18% are positive. Foundation Medicine has $9500 highest and $19 lowest target. $46.13’s average target is -42.55% below currents $80.3 stock price. Foundation Medicine had 16 analyst reports since July 30, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Wednesday, September 21 by UBS. The stock of Foundation Medicine, Inc. (NASDAQ:FMI) has “Buy” rating given on Monday, September 14 by BTIG Research. The stock has “Buy” rating by BTIG Research on Monday, May 15. The stock of Foundation Medicine, Inc. (NASDAQ:FMI) has “Hold” rating given on Thursday, November 3 by Benchmark. Cowen & Co maintained the shares of FMI in report on Wednesday, March 28 with “Buy” rating. The stock of Foundation Medicine, Inc. (NASDAQ:FMI) has “Market Perform” rating given on Thursday, March 8 by Wells Fargo. The rating was downgraded by Wells Fargo to “Market Perform” on Wednesday, September 16. The firm earned “Neutral” rating on Tuesday, March 7 by Janney Capital. The company was downgraded on Thursday, July 30 by JMP Securities. The firm has “Neutral” rating given on Wednesday, November 4 by BTIG Research.

Platinum Investment Management Ltd increased Weibo Corp (NASDAQ:WB) stake by 71,990 shares to 400,016 valued at $41.39 million in 2017Q4. It also upped Alphabet Inc stake by 300 shares and now owns 179,002 shares. Ally Finl Inc (NYSE:ALLY) was raised too.

Investors sentiment increased to 1.39 in 2017 Q4. Its up 0.11, from 1.28 in 2017Q3. It is positive, as 13 investors sold FMI shares while 28 reduced holdings. 33 funds opened positions while 24 raised stakes. 10.07 million shares or 3.72% more from 9.71 million shares in 2017Q3 were reported. Baillie Gifford holds 0.03% or 307,158 shares. 69,504 were accumulated by Schwab Charles Invest Mgmt. Parallax Volatility Advisers Limited Partnership owns 2,226 shares for 0% of their portfolio. Royal Comml Bank Of Canada has 0% invested in Foundation Medicine, Inc. (NASDAQ:FMI) for 280 shares. Teacher Retirement Systems Of Texas owns 4,928 shares for 0% of their portfolio. Seabridge Invest Ltd reported 666 shares stake. Bluecrest Mngmt Ltd holds 3,510 shares. The New York-based Jpmorgan Chase And has invested 0% in Foundation Medicine, Inc. (NASDAQ:FMI). Zurcher Kantonalbank (Zurich Cantonalbank) reported 10,378 shares stake. Oppenheimer And Inc reported 712,960 shares. Benjamin F Edwards & Com reported 106 shares stake. 24,743 are owned by Swiss Fincl Bank. Amundi Pioneer Asset Mngmt Inc holds 0.03% or 274,589 shares. State Of Wisconsin Board holds 0% or 11,000 shares. Bank & Trust Of New York Mellon invested in 66,658 shares or 0% of the stock.

More important recent Foundation Medicine, Inc. (NASDAQ:FMI) news were published by: Seekingalpha.com which released: “Foundation Medicine’s (FMI) CEO Troy Cox on Q1 2018 Results – Earnings Call Transcript” on May 03, 2018, also Streetinsider.com published article titled: “Foundation Medicine (FMI) Says New Liquid Biopsy Assay Granted Breakthrough Device Designation”, Businesswire.com published: “Foundation Medicine, Roche and DIAN Diagnostics Collaborate to Advance Personalized Cancer Care in China” on April 26, 2018. More interesting news about Foundation Medicine, Inc. (NASDAQ:FMI) was released by: Seekingalpha.com and their article: “Foundation Medicine: To Profit From The Increasing Trend Of Personalized Treatment” with publication date: April 23, 2018.

Analysts await ServisFirst Bancshares, Inc. (NASDAQ:SFBS) to report earnings on July, 16. They expect $0.58 earnings per share, up 28.89% or $0.13 from last year’s $0.45 per share. SFBS’s profit will be $30.83M for 18.57 P/E if the $0.58 EPS becomes a reality. After $0.60 actual earnings per share reported by ServisFirst Bancshares, Inc. for the previous quarter, Wall Street now forecasts -3.33% negative EPS growth.

Among 4 analysts covering ServisFirst Bancshares (NASDAQ:SFBS), 0 have Buy rating, 0 Sell and 4 Hold. Therefore 0 are positive. ServisFirst Bancshares had 13 analyst reports since August 25, 2015 according to SRatingsIntel. Raymond James downgraded the shares of SFBS in report on Tuesday, October 18 to “Market Perform” rating. The rating was maintained by Hovde Group on Tuesday, January 31 with “Underperform”. Hovde Group downgraded the stock to “Market Perform” rating in Tuesday, October 13 report. On Wednesday, July 19 the stock rating was maintained by Stephens with “Hold”. The firm has “Hold” rating given on Thursday, October 1 by Sandler O’Neill. The firm has “Market Perform” rating given on Tuesday, October 18 by Hovde Group. The company was upgraded on Tuesday, August 25 by Raymond James. As per Wednesday, March 28, the company rating was maintained by Sandler O’Neill. The firm has “Outperform” rating given on Monday, October 5 by Raymond James. Sandler O’Neill maintained the shares of SFBS in report on Tuesday, January 23 with “Hold” rating.

Foundation Medicine, Inc. (NASDAQ:FMI) Institutional Positions Chart